Literature DB >> 353622

The pharmacology of amblyopia.

F H Duffy, J L Burchfiel, S R Snodgrass.   

Abstract

Physiologic and anatomic evidence has suggested an anatomic disconnection between the deprived eye and visual cortical neurons in cats made amblyopic by monocular deprivation. Clinical and visual-evoked response data suggest, however, that inhibition may play a major role in amblyopia. Accordingly, we intravenously administered anti-inhibitory compounds (bicuculline, ammonium ion, naloxone) to amblyopic cats and demonstrated a substantial restoration of binocular input to the visual cortex. Such pharmacologic reversal suggests that amblyopia is not an anatomically fixed lesion.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 353622     DOI: 10.1016/s0161-6420(78)35648-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  3 in total

1.  A pilot randomized trial of contrast-rebalanced binocular treatment for deprivation amblyopia.

Authors:  Eileen E Birch; Reed M Jost; Serena X Wang; Krista R Kelly
Journal:  J AAPOS       Date:  2020-10-16       Impact factor: 1.220

2.  Psychophysical Reverse Correlation Revealed Broader Orientation Tuning and Prolonged Reaction Time in Amblyopia.

Authors:  Jinli Zhu; Xiaowei Ruan; Cheng Li; Junli Yuan; Yan Yang; Wenhua Zhang; Hanyi Zhang; Zuopao Zhuo; Fang-Fang Yan; Chang-Bing Huang; Fang Hou
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-05-02       Impact factor: 4.925

Review 3.  Pharmacological therapy for amblyopia.

Authors:  Anupam Singh; Ritu Nagpal; Sanjeev Kumar Mittal; Chirag Bahuguna; Prashant Kumar
Journal:  Taiwan J Ophthalmol       Date:  2017 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.